Global Blood Ther (GBT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
68.49 +0.01 (+0.01%) 10/04/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 68.49 unch (unch) -
for Tue, Oct 4th, 2022
Results
download Want to compare other data? Select Fields| Symbol | GBT | KRYS | ALKS | ||
| Company | Global Blood Ther | Krystal Biotech Inc | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 68.48 | 169.49 | 27.93 | ||
| High | 68.49 | 171.85 | 28.28 | ||
| Low | 68.47 | 166.73 | 27.61 | ||
| Last | 68.49 | 169.73 | 27.91 | ||
| Change | +0.01 | +1.67 | +0.07 | ||
| % Change | +0.01% | +0.99% | +0.25% | ||
| Volume | 3,279,900 | 167,600 | 1,517,200 | ||
| 20-Day Average Volume | 2,771,555 | 330,835 | 1,935,705 | ||
| Previous Close | 68.48 | 168.06 | 27.84 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 67.97 | 168.93 | 28.72 | ||
| 20-Day Raw Stochastic | 100.00% | 61.24% | 29.67% | ||
| 20-Day Relative Strength | 79.23% | 48.69% | 37.40% | ||
| Weighted Alpha | +51.60 | -1.50 | +7.99 | ||
| Today's Opinion | 100% Buy | 32% Sell | 40% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.45% since 09/27/22 | +4.83% since 04/21/25 | +3.37% since 04/21/25 | ||
| Low | 67.79 on 09/29/22 | 163.05 on 04/22/25 | 26.81 on 04/22/25 | ||
| High | 68.49 on 10/04/22 | 176.73 on 04/23/25 | 28.28 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +1.02% since 09/02/22 | -7.72% since 03/28/25 | -15.96% since 03/28/25 | ||
| Low | 67.54 on 09/16/22 | 150.10 on 04/09/25 | 25.56 on 04/10/25 | ||
| High | 68.49 on 10/04/22 | 182.15 on 04/02/25 | 33.48 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | +108.81% since 07/01/22 | +6.61% since 01/28/25 | -10.69% since 01/28/25 | ||
| Low | 31.51 on 08/01/22 | 146.00 on 02/12/25 | 25.56 on 04/10/25 | ||
| High | 73.02 on 08/05/22 | 197.94 on 03/25/25 | 36.45 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | +83.62% since 04/04/22 | -4.05% since 10/28/24 | +5.20% since 10/28/24 | ||
| Low | 21.65 on 06/13/22 | 141.72 on 01/14/25 | 25.56 on 04/10/25 | ||
| High | 73.02 on 08/05/22 | 207.84 on 11/11/24 | 36.45 on 02/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,621,431 | 4,904,858 | 4,600,572 | ||
| Shares Outstanding, K | 67,476 | 28,898 | 164,836 | ||
| Annual Sales | 194,750,000 | 290,520,000 | 1,557,630,000 | ||
| Annual Net Income | -303,090,000 | 89,160,000 | 367,070,000 | ||
| Last Quarter Sales | 71,550,000 | 91,140,000 | 429,990,000 | ||
| Last Quarter Net Income | -82,470,000 | 45,480,000 | 146,500,000 | ||
| 60-Month Beta | 0.45 | 0.75 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 08/08/22 | 1.52 on 02/19/25 | 1.04 on 02/12/25 | ||
| Latest Earnings Date | 11/03/22 | 05/06/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 50.62 | 11.50 | ||